Related Experiment Video
Updated: May 4, 2026

05:49
Use of Magnetic Resonance Imaging and Biopsy Data to Guide Sampling Procedures for Prostate Cancer Biobanking
Published on: October 10, 2019
8.4K
It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening
Andrew Vickers1, Sigrid Carlsson2, Vincent Laudone3
1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
European Urology
|January 14, 2014
Abstract:
The benefit-harm ratio of PSA screening can be dramatically improved by avoiding screening, biopsy and treatment in men who are unlikely to benefit, and by referring men that do need treatment to high volume centers.

